More importantly, we verified miR-17-5p negatively regulated CCNG2 mRNA and protein expression by directly targeting its 3’UTR, indicating that miR-17-5p might act as a tumor promoter in HNSCC. The gene discussed is CCNG2; the disease is neoplasm.